Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
| Autor: | Hézode, Christophe, Asselah, Tarik, Reddy, K Rajender, Hassanein, Tarek, Berenguer, Marina, Fleischer-Stepniewska, Katarzyna, Marcellin, Patrick, Hall, Coleen, Schnell, Gretja, Pilot-Matias, Tami, Mobashery, Niloufar, Redman, Rebecca, Vilchez, Regis A, Pol, Stanislas |
|---|---|
| Zdroj: | In The Lancet 20-26 June 2015 385(9986):2502-2509 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|